AAAAAA

   
Results: 1-16 |
Results: 16

Authors: SCHMIDT BH HEINIG R
Citation: Bh. Schmidt et R. Heinig, THE PHARMACOLOGICAL BASIS FOR METRIFONATES FAVORABLE TOLERABILITY IN THE TREATMENT OF ALZHEIMERS-DISEASE, Dementia and geriatric cognitive disorders, 9, 1998, pp. 15-19

Authors: MOLLER JG STASS H HEINIG R BLASCHKE G
Citation: Jg. Moller et al., CAPILLARY-ELECTROPHORESIS WITH LASER-INDUCED FLUORESCENCE - A ROUTINEMETHOD TO DETERMINE MOXIFLOXACIN IN HUMAN-BODY FLUIDS IN VERY SMALL SAMPLE VOLUMES, Journal of chromatography B. Biomedical sciences and applications, 716(1-2), 1998, pp. 325-334

Authors: HEINIG R
Citation: R. Heinig, CLINCIAL PHARMACOKINETICS OF NISOLDIPINE COAT-CORE (VOL 35, PG 191, 1998), Clinical pharmacokinetics, 35(5), 1998, pp. 390-390

Authors: HEINIG R
Citation: R. Heinig, CLINICAL PHARMACOKINETICS OF NISOLDIPINE COAT-CORE, Clinical pharmacokinetics, 35(3), 1998, pp. 191-208

Authors: HEINIG R AHR G HAYAUCHI Y KUHLMANN J
Citation: R. Heinig et al., PHARMACOKINETICS OF THE CONTROLLED-RELEASE NISOLDIPINE COAT-CORE TABLET FORMULATION, International journal of clinical pharmacology and therapeutics, 35(8), 1997, pp. 341-351

Authors: SCHAEFER HG HEINIG R AHR G ADELMANN H TETZLOFF W KUHLMANN J
Citation: Hg. Schaefer et al., PHARMACOKINETIC-PHARMACODYNAMIC MODELING AS A TOOL TO EVALUATE THE CLINICAL RELEVANCE OF A DRUG-FOOD INTERACTION FOR A NISOLDIPINE CONTROLLED-RELEASE DOSAGE FORM, European Journal of Clinical Pharmacology, 51(6), 1997, pp. 473-480

Authors: LANGAN J RODRIGUEZMANAS L SARELI P HEINIG R
Citation: J. Langan et al., NISOLDIPINE CC - CLINICAL-EXPERIENCE IN HYPERTENSION, Cardiology, 88, 1997, pp. 56-62

Authors: WENSING G HEINIG R KUHLMANN J
Citation: G. Wensing et al., PHARMACODYNAMICS AND PHARMACOKINETICS OF BAY-X-7195 AEROSOL, A NEW AND SELECTIVE RECEPTOR ANTAGONIST OF CYSTEINYL-LEUKOTRIENES, IN NORMAL VOLUNTEERS, British journal of clinical pharmacology, 42(2), 1996, pp. 171-178

Authors: MICHELUCCI R CIPOLLA G PASSARELLI D GATTI G OCHAN M HEINIG R TASSINARI CA PERUCCA E
Citation: R. Michelucci et al., REDUCED PLASMA NISOLDIPINE CONCENTRATIONS IN PHENYTOIN-TREATED PATIENTS WITH EPILEPSY, Epilepsia, 37(11), 1996, pp. 1107-1110

Authors: HEINIG R
Citation: R. Heinig, DETERMINATION OF BAYX7195, A NOVEL LEUKOTRIENE D-4 ANTAGONIST, IN HUMAN PLASMA BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY WITH POSTCOLUMN PHOTO DERIVATIZATION AND FLUORESCENCE DETECTION, Journal of chromatography B. Biomedical applications, 667(1), 1995, pp. 137-147

Authors: HEINIG R SCHAEFER HG WENSING G KUHLMANN J
Citation: R. Heinig et al., PHARMACOKINETICS, SAFETY AND TOLERABILITY OF THE ORALLY-ADMINISTERED RECEPTOR ANTAGONIST OF CYSTEINYL-LEUKOTRIENES BAY-X-7195 IN SINGLE-DOSE ESCALATION STUDIES, International journal of clinical pharmacology and therapeutics, 33(10), 1995, pp. 573-579

Authors: HEINIG R MUSCHALEK V AHR G
Citation: R. Heinig et al., DETERMINATION OF THE ENANTIOMERS OF NISOLDIPINE IN HUMAN PLASMA USINGHIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY ON A CHIRAL STATIONARY-PHASE AND GAS-CHROMATOGRAPHY WITH MASS-SELECTIVE DETECTION, Journal of chromatography B. Biomedical applications, 655(2), 1994, pp. 286-292

Authors: WENSING G HEINIG R PRIESNITZ M KUHLMANN J
Citation: G. Wensing et al., EFFECT OF BAY-X-7195, AN ORAL RECEPTOR ANTAGONIST OF CYSTEINYL-LEUKOTRIENES, ON LEUKOTRIENE-D-4 INDUCED BRONCHOCONSTRICTION IN NORMAL VOLUNTEERS, European Journal of Clinical Pharmacology, 47(3), 1994, pp. 227-230

Authors: WENSING G HEINIG R PRIESNITZ M KUHLMANN J
Citation: G. Wensing et al., EFFECT OF BAY-X-7195, AN ORAL RECEPTOR ANTAGONIST OF CYSTEINYL-LEUKOTRIENES, ON LEUKOTRIENE-D-4 INDUCED BRONCHOCONSTRICTION IN NORMAL VOLUNTEERS, European Journal of Clinical Pharmacology, 47(3), 1994, pp. 227-230

Authors: WENSING G HEINIG R KUHLMANN J
Citation: G. Wensing et al., EFFECT OF THE LEUKOTRIENE D-4 (LTD(4))-RECEPTOR ANTAGONIST BAY X 7195ON LTD(4)-INDUCED BRONCHOCONSTRICTION IN NORMAL SUBJECTS, Clinical pharmacology and therapeutics, 55(2), 1994, pp. 203-203

Authors: RABEL SR STOBAUGH JF HEINIG R BOSTICK JM
Citation: Sr. Rabel et al., IMPROVEMENTS IN DETECTION SENSITIVITY FOR THE DETERMINATION OF IVERMECTIN IN PLASMA USING CHROMATOGRAPHIC TECHNIQUES AND LASER-INDUCED FLUORESCENCE DETECTION WITH AUTOMATED DERIVATIZATION, Journal of chromatography. Biomedical applications, 617(1), 1993, pp. 79-86
Risultati: 1-16 |